A Bispecific Antibody Targeting HER2 and HER3 Suppresses Tumor Growth

Cancer Discovery

Abstract

Unbiased phenotypic combinatorial screening uncovers a bispecific antibody (bAb) targeting HER2 and HER3.

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jean-Pascal MachielsSandra Schmitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jennifer Grandis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Mark M Moasser
Clinical Breast Cancer
George W Sledge
© 2022 Meta ULC. All rights reserved